RetinalGenix Technologies Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: RetinalGenix Technologies Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
RetinalGenix Technologies Inc. Debt-to-equity for the quarter ending September 30, 2024 was -103 %, a 3.24% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	-103	-3.25	-3.24%	Sep 30, 2024
Q2 2024	-102	-2.11	-2.11%	Jun 30, 2024
Q1 2024	-101	-0.64	-0.64%	Mar 31, 2024
Q4 2023	-100	+0.02	+0.02%	Dec 31, 2023
Q3 2023	-100	+0.2	+0.2%	Sep 30, 2023
Q2 2023	-100	+1.68	+1.65%	Jun 30, 2023
Q1 2023	-100			Mar 31, 2023
Q4 2022	-100			Dec 31, 2022
Q3 2022	-100			Sep 30, 2022
Q2 2022	-102			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.